Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1244-1253

  Wasser, Shanthi ^a,c   Lim, Ganymede Y ^a   Ong, Choon Nam ^b   Tan, Carolyn E L ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Research Biolabs Pte Ltd   (Singapore)

Author keywords

Cirrhosis; Collagen; Cytochrome P450; Matrix metalloproteinase 13; Placental form of glutathione S transferase; Selenium; Tissue inhibitor of metalloproteinase 1; Transforming growth factor 1

Indexed keywords

ANTIOXIDANT; CARBON TETRACHLORIDE; COLLAGENASE 3; CYTOCHROME P450 2E1; EBSELEN; EOSIN; GLUTATHIONE TRANSFERASE; HEMATOXYLIN; PHENOBARBITAL; PROCOLLAGEN; RETICULIN; SILVER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HISTOLOGY; IMAGE ANALYSIS; LIVER; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILVER IMPREGNATION; STAINING; STEADY STATE; TRICHOME;

EID: 0035702676     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02621.x     Document Type: Article

References (64)

1. Liver fibrosis and extracellular matrix
2. Collagenases and liver fibrosis
3. Growth factor and procollagen type I gene expression in human liver disease
4. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis
5. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
6. Increased transforming growth factor-beta 1 gene expression in human liver disease
7. 1 in human fat-storing cells
8. Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease
9. Connective tissue metabolism and hepatic fibrosis: An overview
10. Transforming growth factorb in tissue fibrosis
11. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
12. Ito-cell gene expression and collagen regulation
13. Cell-matrix interactions in liver
14. Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver
15. Albumin and collagen gene regulation in alcohol- and virus-induced human liver disease
16. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy
17. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
18. Matrix degradation in the liver
19. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes
20. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
21. Proteolytic remodeling of extracellular matrix
22. 4 rat model
23. Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride
24. Liver cirrhosis induced by carbon tetrachloride and the effect of superoxide dismutase and xanthine oxidase inhibitor treatment
25. Fibrogenic effect of oxidative stress on rat hepatic stellate cells
26. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
27. Mechanisms of liver cell injury
28. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes
29. High yield micronodular cirrhosis in the rat
30. Placental glutathione-S transferase (GST-P) as a new marker for hepatocarcinogenesis: In vivo short term screening for hepatocarcinogens
31. Summation of initiation activities of low doses of the non-hepatocarcinogen 1,2-dimethylhydrazine in the liver after carbon tetrachloride administration
32. 1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury
33. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet
34. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin
35. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
36. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activityin vitroand antioxidant capacity of PZ 51 (Ebselen)
37. Ebselen: Prospective therapy for cerebral ischaemia
38. Ebselen: A glutathione peroxidase mimic
39. A novel biologically active selenoorganic compound-IV. Protective glutathione-dependent effect of PZ 51 (Ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes
40. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: Antioxidant actions in addition to hydroperoxide-reducing activity
41. A novel biologically active selenoorganic compound-VII. Biotransformation of ebselen in perfused rat liver
42. 2 cells
43. 1-induced hepatocarcinogenesis in Fischer 344 rats
44. A novel biologically active seleno-organic compound-VI. Protection by ebselen (PZ 51) against galactosamine/ endotoxin-induced hepatitis in mice
45. Increased expression of platelet-derived growth factor A and insulin-like growth factor-1 in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice
46. Induction of early-immediate genes by tumor necrosis factor α contribute to liver repair following chemical-induced hepato-toxicity
47. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
48. TNF-α contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats
49. Expression of hepatocyte growth factor, transforming growth factor α and transforming growth factor-β1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation
50. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model
51. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats
52. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA
53. Experimental models of hepatic fibrosis: A review
54. Hepatic lipocytes. The principal collagen-producing cells of normal rat liver
55. An immunohistochemical and serum ELISA study of type I and III procollagen aminopeptides in primary biliary cirrhosis
56. Collagen types in normal and cirrhotic liver
57. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosisin vivo
58. Cellular sources of collagen and regulation of collagen production in liver
59. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vivo
60. Cellular sources of extracellular matrix proteins in normal and fibrotic liver. Studies of gene expression by in situ hybridization
61. Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver
62. Collagenolytic activity in experimental cirrhosis of the liver
63. Alcoholic liver disease: New insights in pathogenesis lead to new treatments
64. Oxidants, anti-oxidants, and the degenerative diseases of aging